Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers

This study has been completed.
Information provided by:
Medical University of Vienna Identifier:
First received: August 2, 2006
Last updated: December 10, 2007
Last verified: December 2007
The aim of this study is to determine if oxytocin administration is able to blunt LPS induced increase of cytokines (TNF-α) and if there is a change in the endocrine response after lipopolysaccharide administration in humans.

Condition Intervention
Drug: oxytocin

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers

Resource links provided by NLM:

Further study details as provided by Medical University of Vienna:

Primary Outcome Measures:
  • TNF-alpha [ Time Frame: six hours ]

Secondary Outcome Measures:
  • ACTH, cortisol, procalcitonin, IL-1ra, IL-4, IL-6, MIP-1alpha, MIP-1 beta, MCP-1, IP-10, VEGF, body temperature, BNP, Ghrelin, [ Time Frame: six hours ]

Estimated Enrollment: 10
Study Start Date: August 2006

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Men aged 18 years or older with no disease history
  • Written informed consent

Exclusion Criteria:

  • Receiving any medication
  • Probands who suffer from infectious disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00360048

Medical University of Vienna
Vienna, Austria, 1090
Sponsors and Collaborators
Medical University of Vienna
Principal Investigator: Martin Clodi, MD, Associate Professor Medical University of Vienna
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00360048     History of Changes
Other Study ID Numbers: 2006-000246-39
EK-Nr.: 014/2006
Study First Received: August 2, 2006
Last Updated: December 10, 2007

Keywords provided by Medical University of Vienna:

Additional relevant MeSH terms:
Systemic Inflammatory Response Syndrome
Pathologic Processes
Reproductive Control Agents
Physiological Effects of Drugs processed this record on April 27, 2017